AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,550,000 | -30.7% | 399,103 | -2.6% | 0.04% | -25.0% |
| Q2 2021 | $6,562,000 | -15.1% | 409,879 | -5.2% | 0.05% | -17.2% |
| Q1 2021 | $7,727,000 | +22.5% | 432,373 | -7.4% | 0.06% | +23.4% |
| Q4 2020 | $6,306,000 | +2.7% | 466,765 | -10.6% | 0.05% | -13.0% |
| Q3 2020 | $6,142,000 | -17.7% | 521,869 | +3.2% | 0.05% | -18.2% |
| Q2 2020 | $7,466,000 | +31.5% | 505,846 | +20.3% | 0.07% | +3.1% |
| Q1 2020 | $5,677,000 | -56.8% | 420,539 | -22.7% | 0.06% | -34.0% |
| Q4 2019 | $13,154,000 | +25.3% | 544,215 | -0.4% | 0.10% | +18.3% |
| Q3 2019 | $10,501,000 | +9.0% | 546,356 | +67.6% | 0.08% | +12.3% |
| Q2 2019 | $9,635,000 | -37.7% | 326,063 | +0.2% | 0.07% | -33.6% |
| Q1 2019 | $15,465,000 | +276.2% | 325,572 | +185.9% | 0.11% | +233.3% |
| Q4 2018 | $4,111,000 | -87.9% | 113,873 | -79.4% | 0.03% | -84.9% |
| Q3 2018 | $34,052,000 | +37.9% | 553,245 | +51.4% | 0.22% | +25.1% |
| Q2 2018 | $24,685,000 | – | 365,435 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|